Do repost and rate:
By Medha Singh and Shivani Kumaresan (Reuters) – The S&P 500 and the Nasdaq rose on Tuesday as investors flocked to the perceived safety of technology-related stocks as the U.S. pause in the rollout of Johnson & Johnson’s COVID-19 vaccine sparked fears of a delay in a broader economic rebound. The drugmaker’s shares fell 2.2% to a one-month low as U.S. federal health agencies recommended pausing the use of its COVID-19 vaccine after six women developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic. Technology and consumer discretionary sectors, which house high-fl…
